Skip to main content

Table 1 Baseline patient characterictics

From: Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance

Baseline All patients (n = 150) Adverse outcome (n = 17) No adverse outcome (n = 133) p-value
Females 66 (44) 6 (35) 60 (45) 0.45
History of CAD 45 (30) 9 (53) 36 (27) 0.06
History of CHF 24 (16) 6 (35) 18 (14) 0.10
History of smoking 53 (35) 10 (59) 43 (32) 0.06
Diabetes mellitus 44 (29) 9 (53) 35 (226) 0.06
Hypertension 90 (60) 15 (88) 75 (56) 0.01
Hyperlipidemia 111 (74) 13 (76) 98 (74) 0.88
Stroke 10 (7) 1 (6) 9 (7) 0.93
Peripheral vascular disease 7 (5) 2 (12) 5 (4) 0.35
LVEF (%) 58.0 ± 11.7 50.1 ± 16.6 59.5 ± 10.5 0.04
BMI (kg/m2) 29.0 ± 7.0 25.2 ± 9.50 29.0 ± 6.3 0.13
Age (years) 56.0 ± 14.7 65.9 ± 10.8 54.4 ± 14.6 0.01